Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

376.37
+4.391.18%
Post-market: 375.00-1.3700-0.36%19:30 EDT
Volume:396.29K
Turnover:149.44M
Market Cap:42.91B
PE:67.34
High:380.00
Open:370.12
Low:369.49
Close:371.98
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:1.04
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:8.29
PE(LYR):152.38

Loading ...

Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months

Deep News
·
Aug 07

BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field

Deep News
·
Aug 07

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Deep News
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.49% in Regular Trading, Q2 Earnings Significantly Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.48% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.16% Overnight, Q2 Earnings Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

CLSA Maintains Outperform Rating on BEONE MEDICINES, Raises Price Target to HK$321.70

Deep News
·
Aug 07

BEONE MEDICINES Surges Over 4% Intraday as UOB Kay Hian Raises Target Price to HK$265

Deep News
·
Aug 07

BeOne Medicines (ONC) Earnings Beat And Higher Guidance Leave Valuation In Focus

Simply Wall St.
·
Aug 07

Hong Kong Stock Moves: BEONE MEDICINES Surges Nearly 4% After Earnings, Adjusted Net Profit Up 111% YoY in First Half, Solid Tumor Progress Noted

Stock News
·
Aug 07

BeOne Medicines Shares Trading At Discount To Fair Value, RBC Says

MT Newswires Live
·
Aug 07

Beone Medicines : Leerink Partners Raises Target Price to $387 from $377

THOMSON REUTERS
·
Aug 06

Barclays Remains a Buy on BeOne Medicines (ONC)

TIPRANKS
·
Aug 06

Beone Medicines : TD Cowen Raises Target Price to $454 from $424

THOMSON REUTERS
·
Aug 06

Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading

Deep News
·
Aug 06

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Stock News
·
Aug 06

Livermore Index of Leading Chinese Stocks Edges Up 0.1% at Market Open

Deep News
·
Aug 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 05

Major A-Share Developments: Beone Medicines Reports 627% Surge in First-Half Profit

Stock News
·
Aug 05

Beone Medicines Ltd. Increases 2026 Revenue Forecast to Between 44.9 Billion and 46.2 Billion Yuan

Stock News
·
Aug 05